<DOC>
	<DOCNO>NCT01528059</DOCNO>
	<brief_summary>Gastric bypass improve glycemic level type 2 diabetes . However , efficacy may vary different gastric-small intestine reconstruction use procedure . There report Roux en Y reconstruction may give good result . The purpose study compare Roux en Y Billroth II reconstruction patient gastric cancer comorbid type 2 diabetes .</brief_summary>
	<brief_title>Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy Gastric Cancer Comorbid With Type II Diabetes</brief_title>
	<detailed_description>Type 2 diabetes may cause severe complication nephropathy retinopathy . Additionally , associate increase risk cardiovascular event disease . Surgical intervention gastric bypass show attenuate glycemic level obese patient comorbid type 2 diabetes . However , since gastric bypass standard procedure , surgical protocol include stomach small intestine reconstruction may vary . The investigator others find stomach small intestine reconstruction may affect efficacy diabetic treatment . In study , investigator compare efficacy Billroth II Roux en Y reconstruction glycemic control stomach cancer patient type 2 diabetes . Both Billroth II Roux en Y use stomach-small intestine reconstruction subtotal gastrectomy . No difference postoperative outcome quality life report Billroth II Roux en Y reconstruction .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . Diagnosed Type 2 diabetes 2 . Diagnosed gastric cancer 1 . Type 1 diabetes 2 . Unresectable cancer</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Gastric cancer</keyword>
	<keyword>Gastric bypass</keyword>
</DOC>